You are here

Technology transfer

12.07.2019

This program promoted by Biocat is still open: anyone interested can propose challenges or solutions throughout the year

Open Innovation Forum
04.04.2019

The first session hosted 76 meetings between companies and research centers

Who said innovation was the problem?

There is no shortage of talent in the BioRegion of Catalonia nor of research and innovation. Not in the most competitive sectors. As Captain Sparrow said, “The problem is not the problem. The problem is your attitude about the problem.” It is the production model that must change, and above all we have to stop saying we don’t know how to innovate.

“If they could do it, so can you!”

One in four companies created in the BioRegion of Catalonia in the past five years is led by a woman. This percentage is growing, but still far from parity. Women call for greater public visibility so that other female researchers can see them as role models and choose to follow in their footsteps.

A courageous sector with a common goal

What do the biomedical sector and The Lord of the Rings have in common? Courage and a common goal are some of the traits shared by the main characters in this film saga, as well as by researchers, entrepreneurs, investors and other stakeholders who are helping make the BioRegion of Catalonia a benchmark in Europe.

Open Innovation Forum - Núria Martí
10.12.2018

Companies and research stakeholders in the food, healthcare,medtech, chemistry and materials sectors can sign up

Premi Diario Médico
03.12.2018

The Biocat acceleration program was recognized in the Digital Health/Technology category

20.11.2018

Increasing deal flow of projects ready for investment in the BioRegion: this is the main goal of the Investment Readiness Series, a new initiative from Biocat that periodically connects Catalan research projects with local and international investors. Some of the scientists participating in the first edition tell us about the projects they hope will enamor these investors.

30.10.2018

Clinical milestones, new launches and scientific awards round out the headlines in the BioRegion for October

26.09.2018

Baselga’s resignation serves as a bittersweet counterpoint to a September full of good news